News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,820 Results
Type
Article (41415)
Company Profile (272)
Press Release (689115)
Multimedia
Podcasts (91)
Webinars (20)
Section
Business (205037)
Career Advice (2035)
Deals (35608)
Drug Delivery (128)
Drug Development (81596)
Employer Resources (173)
FDA (16513)
Job Trends (14995)
News (347121)
Policy (32773)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2594)
Accelerated approval (47)
Adcomms (27)
Allergies (170)
Alliances (49650)
ALS (211)
Alzheimer's disease (1782)
Antibody-drug conjugate (ADC) (447)
Approvals (16881)
Artificial intelligence (652)
Autoimmune disease (280)
Automation (54)
Bankruptcy (362)
Best Places to Work (11645)
BIOSECURE Act (20)
Biosimilars (219)
Biotechnology (182)
Bladder cancer (186)
Brain cancer (71)
Breast cancer (744)
Cancer (5765)
Cardiovascular disease (466)
Career advice (1725)
Career pathing (41)
CAR-T (330)
CDC (56)
Celiac Disease (3)
Cell therapy (890)
Cervical cancer (47)
Clinical research (70806)
Collaboration (2038)
Company closure (5)
Compensation (1380)
Complete response letters (78)
COVID-19 (2746)
CRISPR (107)
C-suite (1105)
Cystic fibrosis (151)
Data (7757)
Decentralized trials (3)
Denatured (27)
Depression (159)
Dermatology (83)
Diabetes (585)
Diagnostics (6918)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (313)
Drug pricing (200)
Drug shortages (31)
Duchenne muscular dystrophy (280)
Earnings (91917)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119508)
Executive appointments (1075)
FDA (20202)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1707)
Gene editing (232)
Generative AI (55)
Gene therapy (715)
GLP-1 (1049)
Government (4729)
Grass and pollen (6)
Guidances (408)
Healthcare (19002)
HIV (79)
Huntington's disease (56)
IgA nephropathy (96)
Immunology and inflammation (287)
Immuno-oncology (91)
Indications (188)
Infectious disease (3084)
Inflammatory bowel disease (218)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (288)
Interviews (320)
IPO (16677)
IRA (50)
Job creations (3655)
Job search strategy (1432)
JPM (58)
Kidney cancer (19)
Labor market (98)
Layoffs (562)
Leadership (38)
Legal (7955)
Liver cancer (100)
Longevity (32)
Lung cancer (757)
Lymphoma (428)
Machine learning (59)
Management (59)
Manufacturing (1028)
MASH (183)
Medical device (13920)
Medtech (14037)
Mergers & acquisitions (20168)
Metabolic disorders (1485)
mRNA (203)
Multiple sclerosis (187)
NASH (17)
Neurodegenerative disease (412)
Neuropsychiatric disorders (105)
Neuroscience (3279)
Neurotech (1)
NextGen: Class of 2026 (6532)
Non-profit (4531)
Now hiring (77)
Obesity (695)
Opinion (285)
Ovarian cancer (219)
Pain (251)
Pancreatic cancer (294)
Parkinson's disease (356)
Partnered (33)
Patents (592)
Patient recruitment (667)
Peanut (62)
People (59615)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22085)
Phase 2 (31193)
Phase 3 (23205)
Pipeline (8453)
Policy (315)
Postmarket research (2569)
Preclinical (9404)
Press Release (64)
Prostate cancer (294)
Psychedelics (54)
Radiopharmaceuticals (319)
Rare diseases (1067)
Real estate (5981)
Recruiting (70)
Regulatory (25383)
Reports (56)
Research institute (2413)
Resumes & cover letters (354)
Rett syndrome (38)
RNA editing (21)
RSV (88)
Schizophrenia (176)
Series A (287)
Series B (211)
Service/supplier (11)
Sickle cell disease (111)
Special edition (23)
Spinal muscular atrophy (165)
Sponsored (48)
Startups (3645)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (62)
Vaccines (1088)
Venture capital (107)
Weight loss (447)
Women's health (124)
Worklife (20)
Date
Today (214)
Last 7 days (936)
Last 30 days (3419)
Last 365 days (30243)
2026 (11917)
2025 (30215)
2024 (35245)
2023 (40100)
2022 (51230)
2021 (55759)
2020 (54121)
2019 (46564)
2018 (35038)
2017 (32142)
2016 (31521)
2015 (37589)
2014 (31361)
2013 (26382)
2012 (28585)
2011 (29284)
2010 (27353)
Location
Africa (741)
Alabama (92)
Alaska (7)
Arizona (347)
Arkansas (14)
Asia (39733)
Australia (6522)
California (13131)
Canada (3730)
China (1329)
Colorado (563)
Connecticut (571)
Delaware (401)
Europe (85924)
Florida (1961)
Georgia (420)
Hawaii (3)
Idaho (62)
Illinois (1044)
India (88)
Indiana (596)
Iowa (23)
Japan (530)
Kansas (130)
Kentucky (51)
Louisiana (40)
Maine (75)
Maryland (1582)
Massachusetts (9376)
Michigan (358)
Minnesota (709)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (140)
New Hampshire (84)
New Jersey (3453)
New Mexico (29)
New York (3430)
North Carolina (1666)
North Dakota (9)
Northern California (6571)
Ohio (393)
Oklahoma (23)
Oregon (41)
Pennsylvania (2658)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (85)
South Dakota (2)
Southern California (5175)
Tennessee (209)
Texas (2086)
United States (46360)
Utah (392)
Vermont (1)
Virginia (316)
Washington D.C. (80)
Washington State (1054)
West Virginia (4)
Wisconsin (124)
Wyoming (2)
730,820 Results for "sillajen biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arcutis Biotherapeutics, Inc. Announces Termination of Promotion Agreement with Kowa
January 27, 2026
·
5 min read
Press Releases
Sernova Biotherapeutics Announces Closing of Recently Approved Financings
April 23, 2026
·
3 min read
Press Releases
First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases
April 20, 2026
·
3 min read
Press Releases
Northwest Biotherapeutics Announces Establishment Of the Company’s Own Dedicated Leukapheresis Clinic
April 21, 2026
·
4 min read
Press Releases
Nona Biosciences Evolves Brand to Reflect Next Phase of Growth in Biotherapeutic Innovation
May 6, 2026
·
3 min read
Press Releases
Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
April 20, 2026
·
5 min read
Press Releases
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 8, 2026
·
11 min read
Press Releases
FORE Biotherapeutics to Participate in Upcoming Investor Conferences - May 12, 2026
May 12, 2026
·
1 min read
Press Releases
Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates
May 7, 2026
·
15 min read
Press Releases
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
April 10, 2026
·
1 min read
1 of 73,082
Next
